These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8652273)

  • 41. Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression.
    Bánky B; Rásó-Barnett L; Barbai T; Tímár J; Becságh P; Rásó E
    Mol Cancer; 2012 Nov; 11():83. PubMed ID: 23151220
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer.
    Gotley DC; Fawcett J; Walsh MD; Reeder JA; Simmons DL; Antalis TM
    Br J Cancer; 1996 Aug; 74(3):342-51. PubMed ID: 8695347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas.
    Guriec N; Gairard B; Marcellin L; Wilk A; Caldéroli H; Renaud R; Bergerat JP; Oberling F
    Breast Cancer Res Treat; 1997 Jul; 44(3):261-8. PubMed ID: 9266106
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression and modulation of CD44 variant isoforms in humans.
    Mackay CR; Terpe HJ; Stauder R; Marston WL; Stark H; Günthert U
    J Cell Biol; 1994 Jan; 124(1-2):71-82. PubMed ID: 7507492
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium.
    Woerner SM; Givehchian M; Dürst M; Schneider A; Costa S; Melsheimer P; Lacroix J; Zöller M; Doeberitz MK
    Clin Cancer Res; 1995 Oct; 1(10):1125-32. PubMed ID: 9815903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of CD44 splice variants in formalin-fixed, paraffin-embedded specimens of human skin cancer.
    Dietrich A; Tanczos E; Vanscheidt W; Schöpf E; Simon JC
    J Cutan Pathol; 1997 Jan; 24(1):37-42. PubMed ID: 9027631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. De novo expression of CD44 variants in sporadic and hereditary gastric cancer.
    da Cunha CB; Oliveira C; Wen X; Gomes B; Sousa S; Suriano G; Grellier M; Huntsman DG; Carneiro F; Granja PL; Seruca R
    Lab Invest; 2010 Nov; 90(11):1604-14. PubMed ID: 20856229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overexpression of CD44 variant transcripts in rat transplantable thyroid carcinoma lines demonstrating lung metastasis.
    Kitahori Y; Cho M; Konishi N; Ohshima M; Matsui E; Ohnishi T; Imai S; Hiasa Y
    Int J Oncol; 1998 Sep; 13(3):505-11. PubMed ID: 9683785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD44 variant exon v5 encodes a tyrosine that is sulphated.
    Sleeman JP; Rahmsdorf U; Steffen A; Ponta H; Herrlich P
    Eur J Biochem; 1998 Jul; 255(1):74-80. PubMed ID: 9692903
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A CD44 variant exon 6 epitope as a prognostic indicator in breast cancer.
    Schumacher U; Horny HP; Horst HA; Herrlich P; Kaiserling E
    Eur J Surg Oncol; 1996 Jun; 22(3):259-61. PubMed ID: 8654608
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines.
    Stickeler E; Runnebaum IB; Möbus VJ; Kieback DG; Kreienberg R
    Anticancer Res; 1997; 17(3C):1871-6. PubMed ID: 9216637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation of expression of CD44 isoforms and E-cadherin with differentiation in human urothelial cell lines and transitional cell carcinoma.
    Hong RL; Pu YS; Chu JS; Lee WJ; Chen YC; Wu CW
    Cancer Lett; 1995 Feb; 89(1):81-7. PubMed ID: 7533658
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unaltered strong immunohistochemical expression of CD44-v6 and -v5 isoforms during development and progression of oral squamous cell carcinomas.
    Piffkò J; Bànkfalvi A; Klauke K; Dreier R; Joos U; Böcker W; Schmid KW
    J Oral Pathol Med; 1996 Oct; 25(9):502-6. PubMed ID: 8959559
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies.
    Salles G; Zain M; Jiang WM; Boussiotis VA; Shipp MA
    Blood; 1993 Dec; 82(12):3539-47. PubMed ID: 7505117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Up-regulation of the tumour-associated marker CD44V6 in experimental kidney disease.
    Takazoe K; Foti R; Tesch GH; Hurst LA; Lan HY; Atkins RC; Nikolic-Paterson DJ
    Clin Exp Immunol; 2000 Sep; 121(3):523-32. PubMed ID: 10971520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alternative exon-specific PCR method for the analysis of human CD44 isoform expression.
    Lockhart MS; Gravisaco MJ; Mongini C; Waldner C; Alvarez E; Hajos SE
    Oncol Rep; 1999; 6(1):219-24. PubMed ID: 9864432
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Are the products of CD44 exons v5 and v6 markers for metastasis of laryngeal carcinomas?].
    Ostwald J; Pracht O; Rhode E; Kramp B
    Laryngorhinootologie; 1997 May; 76(5):295-9. PubMed ID: 9395420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Newly identified CYP2C93 is a functional enzyme in rhesus monkey, but not in cynomolgus monkey.
    Uno Y; Uehara S; Kohara S; Iwasaki K; Nagata R; Fukuzaki K; Utoh M; Murayama N; Yamazaki H
    PLoS One; 2011 Feb; 6(2):e16923. PubMed ID: 21347438
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD44 and the adhesion of neoplastic cells.
    Rudzki Z; Jothy S
    Mol Pathol; 1997 Apr; 50(2):57-71. PubMed ID: 9231152
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyaluronate binding assay study of transfected CD44 V4-V7 isoforms into the human gastric carcinoma cell line SC-M1.
    Harn HJ; Shen KL; Liu CA; Ho LI; Yang LS; Yueh KC
    J Pathol; 1998 Mar; 184(3):291-6. PubMed ID: 9614382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.